7Baggers
Quarterly
Annual
    Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-06-30 2014-03-31 2013-12-31 2013-06-30 2013-03-31 2012-12-31 2012-06-30 2012-03-31 2011-12-31 2011-06-30 
      
    		                                                     
      cash flow from operating activities
    		                                                     
      net earnings
    		29,100,000 29,000,000 -2,100,000 8,800,000 49,000,000 36,000,000 4,800,000 31,300,000 52,500,000 19,000,000 11,900,000 33,700,000 30,500,000 23,200,000 11,200,000 44,100,000 40,800,000 14,400,000 17,700,000 21,000,000 4,700,000 19,500,000 22,400,000 21,400,000 -441,400,000 48,200,000 -400,000 19,400,000 12,100,000 65,100,000 6,700,000 -148,400,000 54,900,000 65,700,000 33,500,000 52,200,000 36,700,000 66,100,000 23,700,000 -219,400,000 -72,500,000 -88,500,000 105,100,000 64,500,000 98,500,000 107,900,000 87,200,000 84,900,000 129,800,000 70,200,000 77,900,000 143,800,000 65,900,000 
      depreciation and amortization
    		22,100,000 21,800,000 21,700,000 21,400,000 21,700,000 22,400,000 22,500,000 23,300,000 22,500,000 23,100,000 22,500,000 22,800,000 22,500,000 23,200,000 21,400,000 21,200,000 21,500,000 22,200,000 22,200,000 23,300,000 21,000,000 22,000,000 22,500,000 24,600,000 22,800,000 24,300,000 22,100,000 24,200,000 24,200,000 24,400,000 24,800,000 24,100,000 23,400,000 23,500,000 23,400,000 23,400,000 24,600,000 24,400,000 20,200,000 21,800,000 28,900,000 31,400,000 33,200,000 32,900,000 31,500,000 33,400,000 35,100,000       
      share-based compensation expense
    		6,400,000 6,300,000 6,100,000 6,100,000 7,100,000 6,300,000 7,000,000 7,700,000 6,500,000 6,800,000 6,500,000 5,400,000 6,200,000 6,700,000 5,500,000 7,700,000 7,600,000 6,700,000 5,300,000 4,100,000 4,900,000 5,300,000 4,900,000 4,000,000 3,800,000 5,100,000 4,900,000 3,000,000 4,700,000 4,500,000 4,800,000 5,600,000 5,200,000 5,700,000 5,700,000                   
      loss on sale of assets
    		200,000 100,000 1,400,000 400,000 100,000 100,000 100,000 1,400,000 100,000 300,000 700,000 900,000 200,000 100,000 300,000 300,000 200,000 200,000 200,000  900,000 100,000 200,000                               
      deferred compensation payments
    		-500,000 -1,700,000 -200,000 -500,000 -200,000 -1,000,000 -400,000 0 -200,000   -200,000 0 -6,600,000 -500,000 -100,000 -400,000 -8,600,000 -200,000 0 0 -6,800,000 -1,900,000 -200,000 -2,100,000   -1,300,000 -6,300,000   -300,000 -1,900,000                     
      deferred income taxes
    		-400,000 -300,000 200,000 -10,900,000 1,900,000 -400,000 -200,000 -3,900,000 300,000 -800,000 -100,000 -3,100,000 -100,000 -10,400,000 -100,000 10,900,000 -500,000   13,200,000 -600,000 1,200,000 -16,700,000 -2,800,000 -56,500,000 -200,000 -100,000 25,200,000 -400,000 6,400,000 -28,900,000                       
      other
    		-4,200,000 -10,300,000 2,300,000 -7,700,000 -6,000,000 -4,400,000 -600,000 -9,900,000 5,800,000 -17,600,000 -1,800,000 -5,000,000 -3,900,000 -2,600,000 1,700,000 -2,000,000 800,000 -2,600,000 1,000,000 -6,300,000 -1,600,000 3,500,000 5,400,000 -5,400,000 -4,800,000 -600,000 5,100,000 23,600,000 800,000 -100,000 -4,800,000 -3,700,000 -1,100,000 -7,000,000 -4,100,000 -3,600,000 -500,000 -16,200,000 -11,500,000 -9,200,000 -14,300,000 -18,100,000 3,700,000 -6,500,000 -19,900,000 7,100,000 -6,500,000 -15,800,000 -20,500,000 -16,700,000 -16,000,000 3,600,000 500,000 
      changes in operating assets and liabilities
    		62,100,000 200,000 -145,000,000  27,600,000 70,000,000 -106,100,000  78,900,000 54,900,000 -126,000,000  56,900,000 5,500,000 -118,500,000  104,700,000 6,100,000 -128,700,000  45,900,000 18,200,000 -78,500,000  58,800,000 -57,300,000 -78,700,000  59,800,000 2,900,000 -9,700,000                       
      net cash from operating activities
    		114,800,000 45,100,000 -115,600,000 73,700,000 101,200,000   47,800,000    29,600,000    73,100,000    114,000,000    92,400,000    71,400,000 119,900,000   176,800,000    172,300,000    125,100,000 -56,100,000   149,800,000 177,800,000 51,100,000 220,100,000 178,100,000 71,600,000     
      cash flow from investing activities
    		                                                     
      capital expenditures
    		-15,500,000 -17,100,000 -16,800,000 -25,900,000 -12,600,000 -11,500,000 -6,500,000 -18,400,000 -12,300,000 -7,500,000 -11,300,000 -19,000,000 -12,400,000 -15,600,000 -9,400,000 -22,700,000 -11,900,000 -12,000,000 -10,200,000 -20,800,000 -10,100,000 -9,200,000 -7,600,000 -19,300,000 -15,800,000 -13,500,000 -9,400,000 -20,200,000 -14,200,000 -16,000,000 -11,600,000 -23,600,000 -15,000,000 -16,700,000 -13,700,000 -18,600,000 -16,400,000 -20,000,000 -14,500,000 -27,000,000 -35,400,000 -21,700,000 -15,300,000 -18,600,000 -16,100,000 -20,300,000 -21,200,000 -22,700,000 -15,400,000 -24,900,000 -33,500,000 -18,000,000 -23,100,000 
      free cash flows
    		99,300,000 28,000,000 -132,400,000 47,800,000 88,600,000   29,400,000    10,600,000    50,400,000    93,200,000    73,100,000    51,200,000 105,700,000   153,200,000    153,700,000    98,100,000 -91,500,000   131,200,000 161,700,000 30,800,000 198,900,000 155,400,000 56,200,000     
      collection of deferred purchase price on accounts receivable sold
    		3,300,000 1,200,000 1,100,000  100,000    700,000 400,000 400,000  900,000 3,900,000 800,000  400,000 700,000 1,500,000  600,000 500,000 2,800,000  4,000,000 2,500,000 2,500,000                           
      net cash from investing activities
    		-12,300,000 -17,300,000 -15,700,000                                                   
      cash flow from financing activities
    		                                                     
      cash proceeds from debt with original maturities greater than 90 days
    		169,000,000 236,000,000 369,000,000 180,000,000 248,000,000 169,000,000 216,000,000 196,000,000 232,000,000 172,000,000 241,000,000 173,000,000 135,000,000 201,000,000 198,000,000     0 0 0 50,000,000 118,000,000 63,000,000 116,000,000 137,000,000 73,000,000 172,000,000 52,000,000 253,000,000 90,000,000 0 35,000,000 146,000,000 100,000,000 261,000,000 250,500,000 144,800,000               
      cash payments on debt with original maturities greater than 90 days
    		-230,000,000 -244,000,000 -204,000,000  -309,000,000 -271,000,000 -125,000,000 -159,000,000 -323,000,000 -251,000,000 -141,000,000 -139,000,000 -193,000,000       0 0 0 -167,000,000 -126,000,000 -153,000,000 60,000,000 -105,000,000 -66,000,000 -295,000,000 -327,000,000 -100,000,000 -145,000,000 -30,000,000 -106,000,000 -287,000,000 -130,000,000 -240,000,000   0 -1,819,800,000 -200,000 -80,000,000    -125,000,000 0 -106,500,000 -436,500,000 -1,500,000 -1,500,000 -476,500,000 
      (payments for) proceeds from debt with original maturities of 90 days or less
    		                                                     
      repurchase of shares
    		-24,500,000 -35,400,000 -30,300,000 -18,300,000 -9,900,000 -15,300,000 -15,000,000 -30,000,000 -15,200,000 -15,000,000 -15,000,000 -15,200,000 -34,700,000 -50,900,000 -24,500,000 0 0 0 -9,200,000                                   
      dividends to common shareholders
    		-7,200,000 -7,300,000 -7,900,000  -7,500,000 -8,200,000 -7,600,000  -7,700,000 -7,800,000 -8,300,000  -8,000,000 -8,200,000 -8,500,000  -8,300,000                                     
      net financing inflow from the accounts receivable facility
    		13,900,000    2,900,000 -3,400,000 4,800,000                  3,300,000                             
      employee shares withheld for taxes
    		0 -100,000 -7,300,000 -200,000 -100,000 0 -7,000,000 0 -900,000 0 -8,100,000 -300,000 -700,000 0 -9,700,000 -200,000 -1,000,000 0 -3,000,000 -300,000 -200,000 0 -1,500,000 -1,200,000 -300,000 0 -1,500,000 -900,000 -100,000 -100,000 -2,000,000                       
      net cash from financing activities
    		-83,400,000 -37,400,000 109,900,000    69,800,000    82,900,000                24,500,000          -25,100,000 -13,900,000 63,700,000    86,900,000   33,000,000        
      effect of exchange rate changes on cash
    		10,400,000 4,200,000 -12,200,000 4,900,000 -4,200,000 -4,100,000 6,900,000 -5,700,000 700,000 3,600,000 10,000,000 -8,500,000 -7,200,000 -600,000 -3,200,000 -3,300,000 1,000,000 -4,500,000 6,400,000 3,600,000 2,600,000 -3,900,000 3,300,000 -4,900,000 2,100,000 -1,600,000 -1,700,000 500,000 -9,200,000 7,200,000 4,000,000 8,300,000 14,500,000 4,500,000 -14,300,000 1,400,000 -4,200,000 14,100,000 -8,400,000 -2,300,000 14,200,000 -47,900,000 -27,700,000 3,600,000 1,600,000 1,200,000 800,000 -21,500,000 3,500,000 -15,100,000 4,100,000 -4,600,000 5,300,000 
      net decrease in cash and cash equivalents
    		29,500,000 -5,400,000 -33,600,000   -18,000,000 -2,200,000   -28,900,000 -4,600,000   -51,700,000 -239,400,000   1,300,000 -83,900,000   57,000,000 -89,800,000      -25,100,000    52,000,000 -15,600,000 -320,400,000  31,000,000                 
      cash and cash equivalents, beginning of period
    		0 0 209,100,000 0 0 0 216,400,000 0 0 0 188,700,000 0 0 0 479,200,000 0 0 0 364,700,000 0 0 0 341,600,000 0 0 0 266,400,000 0 0 0 502,900,000 0 0 0 738,900,000 0 0 0 712,100,000 0 0 0 1,129,000,000 0 0 998,300,000 0 0 718,500,000 0 0 471,200,000 0 
      cash and cash equivalents, end of period
    		29,500,000 -5,400,000 175,500,000 13,000,000 -100,000 -18,000,000 214,200,000 9,000,000 52,200,000 -28,900,000 184,100,000 7,100,000 -6,500,000 -51,700,000 239,800,000 41,700,000 155,400,000 1,300,000 280,800,000 -147,200,000 203,100,000 57,000,000 251,800,000 62,600,000 34,400,000 4,700,000 239,900,000 47,900,000 -25,100,000 -286,300,000 529,900,000 48,000,000 52,000,000 -15,600,000 418,500,000 47,400,000 31,000,000 -33,700,000 694,200,000 -378,000,000 -24,200,000 -17,300,000 1,131,600,000 97,000,000 110,200,000 881,500,000 98,100,000 63,600,000 787,100,000 70,300,000 84,900,000 476,900,000 29,300,000 
      proceeds from debt with original maturities of 90 days or less
    		 -200,000 3,700,000    4,100,000                                               
      net financing (outflow) inflow from the accounts receivable facility
    		  -13,300,000           1,400,000 -1,600,000     3,200,000 0                                 
      adjustments to reconcile net earnings to net cash flow from operations:
    		                                                     
      defined benefit settlement loss
    		       700,000 0                                             
      changes in current assets and liabilities from operations, net of effects of acquisitions:
    		                                                     
      accounts receivable
    		                                                     
      inventories
    		                                                     
      other current assets
    		                                                     
      accounts payable
    		                                                     
      other current liabilities
    		                                                     
      acquisitions, net of cash acquired
    		                           0 100,000   0 0 0 -34,000,000     0 -1,000,000 0 -11,100,000           
      proceeds from sale of infant care business
    		                                                     
      collection of deferred purchase price from accounts receivable sold
    		                                                     
      net cash used by investing activities
    		   -25,500,000 -17,200,000 -13,700,000 -6,000,000 -18,900,000 -11,600,000 -8,800,000 -11,200,000 -17,800,000 -11,900,000 -13,000,000 -312,700,000         -18,600,000 -13,000,000   -20,200,000 -14,100,000   -11,100,000 -15,000,000 -10,800,000 -47,700,000 -18,600,000 -16,400,000 -20,000,000 -14,500,000 -24,700,000 -35,900,000 -89,600,000 -24,600,000 -15,900,000 -15,500,000 -202,100,000 -20,700,000 -22,200,000 -15,400,000 -24,500,000 -33,300,000 -2,600,000 -25,700,000 
      cash payments for debt with original maturities greater than 90 days
    		                                                     
      net proceeds from (payments for) debt with original maturities of 90 days or less
    		                                                     
      dividends paid to common shareholders
    		                                                     
      net financing inflow (outflow) from the accounts receivable facility
    		         -4,000,000 8,800,000     1,600,000 100,000 -3,500,000 4,200,000        -5,100,000                           
      net cash used by financing activities
    		   -40,100,000 -79,900,000   -14,200,000    3,800,000    -5,500,000 -7,800,000 -46,600,000 -5,500,000 2,900,000    -6,300,000    -3,800,000 -121,700,000               -40,500,000   -102,100,000       
      net increase in cash and cash equivalents
    		   13,000,000    9,000,000    7,100,000    41,700,000    -147,200,000       -26,500,000    27,000,000        -17,900,000 -378,000,000       98,100,000 63,600,000 68,600,000     
      supplemental disclosures of cash flow information:
    		                                                     
      cash paid for interest
    		                                                     
      cash paid for income taxes
    		                                                     
      proceeds from (payments for) debt with original maturities of 90 days or less
    		                                                     
      net cash used by operating activities
    		      -72,900,000    -86,300,000   39,100,000 -79,000,000    -82,500,000    -46,900,000    -46,400,000    -21,000,000   58,600,000 -59,000,000    -58,700,000               
      cost of early retirement of long-term debt
    		               0 0   0                                  
      cash proceeds from the issuance of senior notes due 2029
    		               0 0                                     
      cash payments on senior notes due 2022
    		               0 0                                     
      net increase in debt with original maturities of 90 days or less
    		          5,500,000 400,000 -5,000,000 -700,000 1,400,000 1,800,000 1,700,000 -1,800,000 2,500,000 1,300,000 -700,000       -9,900,000 1,400,000   1,900,000 -1,100,000     -3,400,000 -2,200,000 17,900,000 -494,600,000 35,900,000 188,200,000 124,600,000 70,600,000 58,300,000 46,400,000 -57,100,000 131,100,000 5,300,000 -84,000,000 120,900,000  
      debt issuance costs for senior notes due 2029
    		               0 -600,000                                     
      dividends paid
    		                                                     
      acquisition of billie, net of cash acquired
    		            0 -600,000 -308,800,000                                       
      proceeds from sale of infant and pet care business
    		            0 0 5,000,000  0 0 7,500,000  0 0 95,800,000                               
      proceeds (payments) of debt with original maturities of 90 days or less
    		                                                     
      net cash from (used by) operating activities
    		                                                     
      (payments) proceeds of debt with original maturities of 90 days or less
    		                                                     
      net cash (used by) from financing activities
    		                     5,400,000 -135,900,000          -67,300,000 -67,900,000 -199,400,000                   
      gain on sale of infant and pet care business
    		                   0 0 1,100,000 -5,200,000                               
      investment in equity securities
    		                                                     
      cash proceeds from the issuance of senior notes due 2028
    		                   0                                  
      cash payments on senior notes due 2021
    		                   0                                  
      debt issuance costs for senior notes due 2028
    		                   -1,300,000                                  
      debt issuance costs for the revolving credit facility
    		                   0                                  
      acquisition of cremo
    		                0 0 -300,000                                   
      net cash from (used by) financing activities
    		             -77,200,000 155,500,000                34,500,000                       
      impairment charge
    		                           0                          
      proceeds from sale of other assets
    		                                                     
      term loan repayment
    		                       0 0                             
      net cash (used by) from investing activities
    		                -12,500,000 -11,300,000 -2,300,000        -2,900,000                           
      net cash (used by) from operating activities
    		                                                     
      gain on sale of assets
    		                        500,000 200,000 700,000                           
      non-cash sun care reformulation costs
    		                                                     
      non-cash restructuring costs
    		                               400,000 3,600,000 1,100,000 1,700,000 1,700,000 1,000,000 500,000 700,000 600,000 29,800,000    2,800,000 4,400,000 7,300,000 5,700,000 23,400,000     
      proceeds from sale of playtex gloves assets
    		                                                     
      common shares purchased
    		                           0 0 -9,200,000 -115,200,000 -70,800,000 -36,100,000 -500,000 -58,000,000 -82,100,000 -35,600,000 0 -78,900,000               
      impairment charges
    		                                                     
      proceeds from sale of assets
    		                       0 100,000 0 4,000,000 0 0 2,600,000 2,100,000 12,500,000 0       2,300,000 500,000 12,000,000 1,800,000 4,300,000 800,000 3,500,000 600,000 600,000 100,000 200,000 2,100,000 16,900,000 200,000 
      net cash from (used by) from investing activities
    		                    -9,800,000 -8,600,000 89,700,000                               
      net decrease in debt with original maturities of 90 days or less
    		                      -100,000   4,400,000 -900,000    -1,300,000    -400,000                   
      net financing outflow from the accounts receivable facility
    		                      -14,900,000                               
      (gain) loss on sale of assets
    		                                                     
      changes in current assets and liabilities used in operations, net of effects of business acquisitions:
    		                                                     
      playtex glove sale
    		                                                     
      net increase increase in debt with original maturities of 90 days or less
    		                                                     
      playtex gloves sale
    		                            0 0 19,000,000                       
      net increase (decline) in cash and cash equivalents
    		                                                     
      international pension funding
    		                                   0 0                 
      (gain) / loss on sale of assets
    		                            600,000 300,000 -13,900,000                       
      excess tax benefits from share-based payments
    		                                        100,000 800,000 8,400,000 1,700,000 400,000 4,000,000 300,000 2,300,000 2,500,000 1,600,000 100,000 400,000 300,000 
      net cash from (used by) investing activities
    		                              9,500,000                       
      venezuela deconsolidation charge
    		                                       0 0             
      change related to venezuelan operations
    		                                       0 0             
      change in restricted cash
    		                                       0 0             
      deferred finance expense
    		                                   0    0              
      cash dividends paid
    		                                       0 -31,100,000 -31,000,000 -31,100,000 -30,900,000 -30,800,000 -31,300,000 -24,900,000 -24,800,000 -24,800,000     
      transfer of cash and cash equivalents to new energizer
    		                                                     
      proceeds from issuance of common shares
    		                                       0              
      changes in current assets and liabilities used in operations
    		                                35,700,000 -5,200,000 -118,700,000  16,500,000 1,800,000 -105,400,000  -29,100,000 23,500,000 -184,300,000 48,100,000 50,300,000 -149,000,000 81,100,000 40,800,000 -99,600,000     
      non-cash items included in income
    		                                  -500,000 -9,900,000 -1,600,000 10,000,000 13,600,000 100,000 1,100,000 9,300,000 8,900,000 9,700,000 14,600,000 47,300,000 15,900,000 -11,400,000 75,900,000 54,800,000 58,400,000 54,600,000 68,000,000 
      net pension and postretirement gains
    		                                                     
      cash proceeds from issuance of debt with original maturities greater than 90 days
    		                                       190,200,000              
      common stock purchased
    		                                           0      -75,600,000 0 -135,900,000 0 
      proceeds from issuance of common stock
    		                                         2,900,000 1,400,000 4,200,000 500,000 2,000,000 1,100,000 8,800,000 6,600,000 500,000 600,000 1,200,000 1,500,000 
      net cash from/(used by) financing activities
    		                                                8,900,000    -20,800,000 
      non-cash restructuring costs related to asset impairment/accelerated depreciation
    		                                          1,400,000           
      net cash (used by)/from operating activities
    		                                          -32,000,000           
      net increase/(decrease) in cash and cash equivalents
    		                                          2,600,000       70,300,000 84,900,000 5,700,000  
      pension curtailment
    		                                              0 0 -37,400,000     
      feminine care acquisition
    		                                           -1,800,000 0 -185,300,000        
      net (decrease)/increase in cash and cash equivalents
    		                                            110,200,000 -116,800,000       29,300,000 
      operating cash flow before changes in working capital
    		                                              139,000,000 137,300,000 171,200,000 108,300,000 120,300,000 202,000,000 134,400,000 
      cash proceeds from issuance of debt with maturities greater than 90 days, net of discount
    		                                                     
      payment of debt issue cost
    		                                                     
      cash flow from operations
    		                                                     
      changes in current assets and liabilities used in operations, net of effects of business acquisition
    		                                                 11,800,000 78,600,000 -174,200,000 -63,900,000 
      net cash from operations
    		                                                 120,100,000   70,500,000 
      acquisition, net of cash acquired
    		                                                    0 
      net cash (used by)/from financing activities
    		                                                 -10,200,000 -84,800,000 -14,900,000  
      net sales
    		                                                     
      personal care
    		                                                 22,000,000 87,100,000 564,400,000 114,900,000 
      household products
    		                                                 300,000 -183,400,000 633,700,000 84,300,000 
      total net sales
    		                                                 22,300,000 -96,300,000 1,198,100,000 199,200,000 
      operating profit
    		                                                     
      total operating profit
    		                                                 -18,500,000 -74,900,000 272,300,000  
      general corporate and other incomes
    		                                                 10,800,000 -6,900,000 -36,700,000 9,100,000 
      household products restructuring
    		                                                 1,000,000 -10,700,000 9,200,000 15,700,000 
      acquisition inventory valuation
    		                                                     
      litigation provision
    		                                                     
      asr integration/transaction costs
    		                                                 0 -900,000 -1,500,000  
      amortization
    		                                                 200,000 -100,000 -5,700,000 200,000 
      venezuela devaluation/other impacts
    		                                                     
      cost of early debt retirements
    		                                                     
      interest and other financing items
    		                                                 -4,200,000 -1,900,000 -29,200,000 -1,000,000 
      total earnings before income taxes
    		                                                 -24,200,000 -95,400,000 208,400,000 39,900,000 
      net cash from/(used by) operations
    		                                                   27,800,000  
      cash proceeds from issuance of debt with maturities greater than 90 days
    		                                                     
      net increase/(decrease) in debt with original maturities of 90 days or less
    		                                                    -138,500,000 
      segment profit
    		                                                     
      total segment profit
    		                                                     
      asr transaction costs/integration
    		                                                    -2,500,000 
      venezuela devaluation/non-operating impacts
    		                                                     
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.